News


All News

Dr. Skin hired several people to improve the marketing of his practice. In order to make things simple, he provided them with all of his patients' records to allow them easy access to patient demographic information. Dr. Skin is assured by colleagues that although the involved activity may represent a HIPAA violation, no penalties have been assessed to small practices such as his. Is this true?

In the quest for new vaccines, developers must balance clinical promise with practical concerns, said Kenneth Tomecki, M.D., at the 70th annual meeting of the American Academy of Dermatology. "The future for vaccines is very encouraging," says Dr. Tomecki, vice chairman, department of dermatology, Cleveland Clinic.

If you’re like most Americans, you feel less secure about the U.S. economy. Certainly, this is justified. Western European countries have run out of capital, unemployment-based riots have broken out in the streets of Great Britain, and the United States debt shield political debacle has caused our government debt to be downgraded from “AAA” for the first time in history.

Sentinel lymph node biopsy (SLNB) for management of localized primary melanoma continues to have its critics, but Alistair Cochran, M.D., says that current data supports the procedure as a standard approach for staging patients with clinically localized, intermediate-thickness melanoma.

The safety and versatility of photodynamic therapy (PDT) make it a worthwhile addition for dermatologists not yet providing this treatment, according to Amy Forman Taub, M.D., who spoke at the 2011 annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery.

Men do not get onychomychosis more frequently than do women, and the disease is no more severe than it is in female patients. Men may, however, be more likely than women to view the condition as cosmetic and, therefore, delay treatment, according to Nardo Zaias, M.D.

Cohera Medical, a developer of absorbable surgical adhesives and sealants, has secured more than $8.4 million toward Series D financing through private investors, which the company reportedly will use to expand adoption of its TissuGlu Surgical Adhesive product in Germany and additional European markets.

Alma Lasers has signed an agreement to acquire the assets of Quantel Derma, (formerly known as Wavelight), a France- and Germany-based developer of laser technologies for dermatologists. The transaction was expected to be finalized in July.

People beset by some sort of phobic anxiety - and 8 percent of Americans have at least one - may be more prone than others to faster biological aging and related health problems, a recent study suggests.

Researchers may have come closer to finding more effective treatment for Parkinson's disease by investigating signs of the disease in patient-derived skin cells and testing how the cells respond to drug therapy.